Executive Series - Bionomics Ltd (BNO) CEO & MD, Dr Deborah Rathjen


CommSec’s Tom Piotrowski speaks with Bionomics Ltd (BNO) CEO & MD, Dr Deborah Rathjen about the company’s newly signed deals with Merck, its new anxiety drug trial and its cancer treatment trials To view more Executive Series interviews, visit: (VIEW LINK)


CommSec is Australia's leading online broker. CommSec has been committed to providing the best in online trading since 1995. CommSec helps make informed investment decisions with comprehensive market research, free live pricing and powerful...

bno Executive Series Bionomics


Please sign in to comment on this wire.